Pharmalittle: We're reading about RFK Jr. targeting antidepressants, J&J pushing an IBD drug, and more

Kennedy Pushes Review of Antidepressants

Health Secretary Robert F. Kennedy Jr. is pushing for a federal review of antidepressants and other psychiatric medications as part of the “Make America Healthy Again” effort. The New York Times reports that the initiative takes aim at selective serotonin reuptake inhibitors, such as Zoloft, Lexapro, Paxil, and Prozac. “Psychiatric medications have a role in care, but we will no longer treat them as the default, we will treat them as one option,…

Pharmalittle: We're reading about RFK Jr. targeting antidepressants, J&J pushing an IBD drug, and more

BioNTech plans to close sites affecting up to 1,860 jobs and buy back up ​to $1 billion worth of its shares.

J&J's IBD combo fails Phase 2 studies, but will move into pivotal testing

Johnson & Johnson will move a treatment for inflammatory bowel disease into Phase 3 studies despite the therapy's failure in two mid-stage trials. The company said that JNJ-4804, a combination of the blockbuster drugs Tremfya ...